The main market opportunities in Syndromic Multiplex Diagnostics include the merging of Point of Care Testing and Molecular Diagnostics, which is streamlining frontline test protocols while reducing ...

Key opportunities in the Human Metapneumovirus Diagnostics Market include the growing use of multiplex testing panels for ...

Caledonia TX Ltd has commissioned its North Ayrshire DAB digital radio network, bringing additional digital capacity and new ...

NanoMosaic's technology is designed to support upstream and downstream process development, quality control, and release testing.

The global antibody testing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% between ...

DENVER, Jan. 15, 2026 /PRNewswire/ -- QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a significant expansion of its molecular ...

The FDA AMT designation verifies NanoMosaic platform's ability to enhance efficiency, product quality, and scalability across AAV gene therapy manufacturing.

The theatre chain's F&B net revenue went up 14% at Rs 593.8 crore in Q3 FY26 and in nine months of FY26 it increased 16% at ...

Multicenter examination showed biomarkers in cerebrospinal fluid consistently distinguished MS from other ...

In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.

Co-Diagnostics lost its place on the Nasdaq after consistently failing to meet the exchange's minimum bid price requirement. In a last-ditch effort to regain compliance, the company executed a ...

Danaher Corporation (NYSE:DHR) Q4 2025 Earnings Call Transcript January 28, 2026 Danaher Corporation beats earnings ...